Kyle Piskel - 14 Mar 2025 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Financial Officer
Signature
/s/ Kyle Piskel
Issuer symbol
ADPT
Transactions as of
14 Mar 2025
Transactions value $
$15,800
Form type
4
Filing time
17 Mar 2025, 19:34:22
Previous filing
06 Mar 2025
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $15.8K +2.5K +0.93% $6.32 272K 14 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -2.5K -100% $0.00 0 14 Mar 2025 Common Stock 2.5K $6.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was fully vested and exercisable.